24小时热门版块排行榜    

查看: 11429  |  回复: 114
【奖励】 本帖被评价92次,作者1949stone增加金币 73.2

1949stone

荣誉版主 (知名作家)


[资源] Drug Discovery and Evaluation: Pharmacological Assays

Drug Discovery and Evaluation: Pharmacological Assays

The third edition of the book Drug Discovery and Evaluation. Pharmacological
Assays is presented here.
The volume of data has risen considerably compared to the second edition. In
particular, a large number of assays have been added. Meanwhile, data on Safety
Pharmacology have been removed from this edition. An extended discussion of that
important aspect of pharmacology was published in the book Drug Discovery and
Evaluation. Safety and Pharmacokinetic Assays, edited by H. G. Vogel, F. J. Hock,
J. Maas, and D. Mayer, by Springer in 2006.
Several of my colleagues provided essential contributions to this edition. In particular
I am indebted to S. A. Mousa for rewriting the chapter Pharmacological
Assays in Thrombosis and Hemostasis, S. G. E. Hart, for rewriting the chapter Activity
on Urinary Tract, G. Müller for rewriting and amending the chapter Antidiabetic
Activity, B. Schultz for amending the chapter Ophthalmologic Activity, and
J. Sandow for rewriting the chapter Endocrinology. All chapters have been revised
and thoroughly updated as well.
The approach to drug discovery is changing continuously. Decades ago, many
drugs were found by serendipity in clinical trials. Most new drugs, however, were
found by the classical approach in animal experiments. This approach has the advantage
of relatively high predictability, but it also has the disadvantage that little
information is provided about the molecular mechanisms involved in the observed
effects, and the detection of drugs with new mechanisms always required new models.
It is generally believed that the costs of developing new pharmaceutical drugs
are exploding, while the output of new drugs is actually decreasing. A change
in paradigm, the target-based or mechanism-based drug discovery approach, was
therefore welcomed with great enthusiasm. The techniques of combinatorial chemistry
could generate thousands of compounds to be tested against thousands of targets
using high-throughput and ultra-high-throughput technology with tremendous
capacity. This made it highly effective for the identification of target-selective compounds.
However, despite the fact that this approach is very advantageous from a
scientific and practical viewpoint, it did not translate into a high success rate in the
discovery of new drugs. This has naturally led to questions regarding the success of
target-based drug discovery and, more importantly, a search for alternatives.
The target-based approach has therefore been replaced again by the physiologybased
approach, the classical drug discovery paradigm, or the function-based approach,
which seeks to induce a therapeutic effect by normalizing a disease-specific
abnormality.
On top of this, important changes in the management of some of the larger drug
companies have taken place in recent years. Modern managers were installed as
chief executive officers and other high-level executives, quite often with little or
no biological and technical experience. They were more interested in blockbusters
and in shareholders’ value than finding new drugs, especially for rare diseases.
Research workers were confronted with cumbersome and inflexible organizational
structures characterized by regimentation, control, conformity, and excessive bureaucracy.
Consequently, creativity and productivity decreased in this environment.
Recently, however, there are signs that the situation is changing.
In this book we ask the question: “Quo vadis, pharmacology?” We suggest giving
pharmacologists the freedom, time, and money to carry out their own ideas.
We also describe animal models of rare diseases that enable the medically trained
pharmacologist to find appropriate drugs.
We are well aware that the rapid progress in biology will once again change the
methodological approach in the coming years, and that electronicmedia will continuously
help the researcher to access and share information. However, it is becoming
more and more evident that many young pharmacologists have only limited training
in classical pharmacological methodologies.When searching for these methods,
researchers will only find insufficient information on the methodological details in
the electronic databases currently available. To this end, we hope the current book
may bridge this gap by comprehensively covering those pharmacological methods
utilized for over more than a hundred years.
At this point I would like to express my sincere thanks to all colleagues who
contributed to the new and to the earlier editions of this book. Their names and
affiliations are given in alphabetical order.
Spring 2007 H. Gerhard Vogel
回复此楼

» 本帖附件资源列表

  • 欢迎监督和反馈:小木虫仅提供交流平台,不对该内容负责。
    本内容由用户自主发布,如果其内容涉及到知识产权问题,其责任在于用户本人,如对版权有异议,请联系邮箱:xiaomuchong@tal.com
  • 附件 1 : Drug_Discovery_and_Evaluation-Pharmacological.pdf
  • 2015-09-21 20:06:21, 22.2 M

» 收录本帖的淘帖专辑推荐

自然科学

» 本帖已获得的红花(最新10朵)

» 猜你喜欢

已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

zeng_2014

捐助贵宾 (正式写手)


非常感谢!
49楼2015-09-26 07:36:09
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
简单回复
2015-09-21 20:12   回复  
五星好评  顶一下,感谢分享!
work0373楼
2015-09-21 22:03   回复  
五星好评  顶一下,感谢分享!
pingshan4楼
2015-09-21 22:21   回复  
五星好评  顶一下,感谢分享!
wang3695楼
2015-09-21 23:24   回复  
五星好评  顶一下,感谢分享!
2015-09-22 08:02   回复  
五星好评  顶一下,感谢分享!
wangzgsh7楼
2015-09-22 08:13   回复  
五星好评  顶一下,感谢分享!
2015-09-22 08:27   回复  
五星好评  顶一下,感谢分享!
2015-09-22 08:29   回复  
顶一下,感谢分享!
2015-09-22 08:41   回复  
五星好评  顶一下,感谢分享!
taolubee11楼
2015-09-22 08:43   回复  
五星好评  顶一下,感谢分享!
甾酮12楼
2015-09-22 09:00   回复  
五星好评  顶一下,感谢分享!
dudubaobao13楼
2015-09-22 09:16   回复  
五星好评  顶一下,感谢分享!
Bookaholic14楼
2015-09-22 11:17   回复  
五星好评  顶一下,感谢分享!
quietdon15楼
2015-09-22 14:44   回复  
五星好评  顶一下,感谢分享!
plumty16楼
2015-09-22 14:45   回复  
五星好评  顶一下,感谢分享!
lewzman17楼
2015-09-22 15:10   回复  
五星好评  顶一下,感谢分享!
zengx618楼
2015-09-22 18:08   回复  
五星好评  顶一下,感谢分享!
gpwang52619楼
2015-09-22 20:20   回复  
五星好评  顶一下,感谢分享!
qiute62120楼
2015-09-22 20:28   回复  
五星好评  顶一下,感谢分享!
sjshvdc21楼
2015-09-22 21:04   回复  
五星好评  顶一下,感谢分享!
susufairy22楼
2015-09-22 21:46   回复  
五星好评  顶一下,感谢分享!
kuanghua23楼
2015-09-22 21:48   回复  
五星好评  顶一下,感谢分享!
hamakun24楼
2015-09-22 21:52   回复  
五星好评  顶一下,感谢分享!
2015-09-22 23:17   回复  
五星好评  顶一下,感谢分享!
msd2phd26楼
2015-09-23 07:59   回复  
五星好评  顶一下,感谢分享!
m20077015427楼
2015-09-23 09:37   回复  
五星好评  顶一下,感谢分享!
sunlong28楼
2015-09-23 11:07   回复  
五星好评  顶一下,感谢分享!
Bookaholic29楼
2015-09-23 11:14   回复  
顶一下,感谢分享!
yanzr30楼
2015-09-23 12:41   回复  
五星好评  顶一下,感谢分享!
2015-09-23 12:51   回复  
五星好评  顶一下,感谢分享!
huliyong32楼
2015-09-23 13:30   回复  
五星好评  顶一下,感谢分享!
2015-09-23 14:03   回复  
五星好评  顶一下,感谢分享!
chemorgren34楼
2015-09-23 16:37   回复  
五星好评  顶一下,感谢分享!
hxj2001hy35楼
2015-09-23 20:44   回复  
五星好评  顶一下,感谢分享!
lindoudou36楼
2015-09-23 22:54   回复  
五星好评  顶一下,感谢分享!
2015-09-24 08:38   回复  
五星好评  顶一下,感谢分享!
xpjdzh75238楼
2015-09-24 09:22   回复  
五星好评  顶一下,感谢分享!
mslab39楼
2015-09-24 13:52   回复  
五星好评  顶一下,感谢分享!
sunmh200340楼
2015-09-25 08:25   回复  
五星好评  顶一下,感谢分享!
liqide41楼
2015-09-25 08:41   回复  
五星好评  顶一下,感谢分享!
amunesia42楼
2015-09-25 13:23   回复  
五星好评  顶一下,感谢分享!
jason_0843楼
2015-09-25 17:44   回复  
五星好评  顶一下,感谢分享!
xuhaijiang44楼
2015-09-25 21:38   回复  
五星好评  顶一下,感谢分享!
pumcnsy45楼
2015-09-25 21:40   回复  
五星好评  顶一下,感谢分享!
Brucezs46楼
2015-09-25 21:49   回复  
三星好评  顶一下,感谢分享!
alanyeung47楼
2015-09-25 22:45   回复  
五星好评  顶一下,感谢分享!
zeng_201448楼
2015-09-26 07:36   回复  
五星好评  顶一下,感谢分享!
wang36950楼
2015-09-26 10:57   回复  
顶一下,感谢分享!
相关版块跳转 我要订阅楼主 1949stone 的主题更新
☆ 无星级 ★ 一星级 ★★★ 三星级 ★★★★★ 五星级
普通表情 高级回复 (可上传附件)
最具人气热帖推荐 [查看全部] 作者 回/看 最后发表
[基金申请] 关于filecode,很负责任的告诉大家 +6 爱看书的可乐 2026-08-08 7/350 2026-08-08 22:13 by a_niu
[基金申请] 关于豆爷回答的JTJC与%2F数量 +5 yang182083 2026-08-06 7/350 2026-08-08 18:29 by zhanghaozhu
[基金申请] 国基金的申报应该改成非等额制,评价高的钱多评价低的钱少,但是增加资助率 +7 a089 2026-08-07 7/350 2026-08-08 18:05 by gltch
[基金申请] 好奇怪的filecode +3 布布和一二 2026-08-08 4/200 2026-08-08 17:46 by zhanghaozhu
[考研] 售SCI一区T0P文章,我:8.O55.1.O.54,科目全,可十急 +3 qTvzQBRAHjCi 2026-08-07 5/250 2026-08-08 16:47 by oEVWOejN9taj
[基金申请] 售SCI文章,我:8O.5.5.1O.54,科目全,可十急 +3 Vi50GxzrFcSG 2026-08-07 5/250 2026-08-08 16:27 by oEVWOejN9taj
[考博] 售一区SCI文章T0P,我:8O.551.O54,科目全,可十急 +3 Vi50GxzrFcSG 2026-08-07 4/200 2026-08-08 16:22 by oEVWOejN9taj
[论文投稿] 售SCI一区文章,我:8.O.55.1.O.54,科目齐全,可伽急 +3 Vi50GxzrFcSG 2026-08-07 6/300 2026-08-08 15:07 by oEVWOejN9taj
[硕博家园] 售SCI一区文章,我:8.O.55.1.O.54,科目齐全,可伽急 +4 HEQlVqMTIA7d 2026-08-07 6/300 2026-08-08 14:47 by oEVWOejN9taj
[公派出国] 售SCI文章,我:8O5.5.1.O.54,科目齐全,可+急 +3 HEQlVqMTIA7d 2026-08-07 6/300 2026-08-08 14:39 by oEVWOejN9taj
[教师之家] 售SCI一区T0P文章,我:8.O.55.1.O54,科目全,可伽急 +4 HEQlVqMTIA7d 2026-08-07 5/250 2026-08-08 14:27 by oEVWOejN9taj
[基金申请] 化学口download_prp&fileCode的固定段好像这几天一直没变,有变的大神么? +3 Tide man 2026-08-07 4/200 2026-08-07 22:39 by Tide man
[基金申请] 固定端突然变了,今天 +6 archvillain 2026-08-06 10/500 2026-08-07 16:03 by 医学老男孩
[基金申请] filecode变化情况 +6 布布和一二 2026-08-07 22/1100 2026-08-07 14:45 by 且听虎啸
[基金申请] 大家散了吧,后缀研究没有意义,别浪费时间了,过好目前的每一天,不要焦虑 +5 Tide man 2026-08-06 7/350 2026-08-07 13:11 by 医学老男孩
[基金申请] filecode +14 等待解的谜 2026-08-06 19/950 2026-08-07 12:20 by wlwhappy
[基金申请] 好消息?这个有何含义??? +8 Tide man 2026-08-05 10/500 2026-08-05 16:14 by xmuxiaoyu
[基金申请] 纯娱乐,不喜欢勿喷 +7 Tide man 2026-08-04 10/500 2026-08-04 15:10 by loufangrui
[基金申请] 面上提前没消息,有中的吗 +14 archvillain 2026-08-02 18/900 2026-08-04 14:42 by archvillain
[基金申请] 什么时候能放榜呀? +3 Jacob678 2026-08-03 3/150 2026-08-03 16:14 by gltch
信息提示
请填处理意见